LATEST

6 puzzling cases to crackWe know you love a good diagnostic challenge. Can you solve these 6 cases that we've featured over the past year?
AD drug development driven by symptom and disease controlDrug development for established atopic dermatitis focuses on both managing flares and long-term disease control.
False moisturizer claims may worsen skin conditionsMost moisturizes contain ingredients that are not advertised and could potentially harm some patients, study shows.
Restarting TNFi treatment after a break proves beneficial in psoriasisSwitching from adalimumab to etanercept or vice versa after interruption can improve treatment response, data presented in London suggests.
Hard-to-treat psoriasis cases respond to secukinumabSecukinumab has been shown to be effective for the treatment of moderate-to-severe plaque psoriasis in hard-to-treat patients who failed anti-TNFa treatment, researchers report in London.
Promising results for risankizumab continue in phase 3 trialsPhase three trials of the selective IL-23 blocker risankizumab are replicating the promising results achieved by phase two trials for psoriasis, researchers report in London.
Top 5 legal questionsAs the field of medicine becomes more complex, so do the legal questions that can mean the difference between a lawsuit with a positive result and one with a negative result. Dr. Goldberg looks at 5 potential situations and offers his advice.
Psoriasis patients have a heightened risk of malignant lymphomaPatients with psoriasis are more likely than the general population to receive a diagnosis of malignant lymphoma. Why? Cutaneous T-cell lymphoma is misdiagnosed as psoriasis and can also be mistaken for atopic dermatitis due to similarities in the skin manifestation.
Caffeine can reduce inflammation in patients with eczema and psoriasisAdding caffeine to topical skin treatments would be a simple way to reduce inflammation in patients with atopic dermatitis and psoriasis, suggests a review presented at the Psoriasis: From Gene to Clinic International Congress, which took place in London this week.
A new year and new demands
A new year and new demandsIn this slideshow, we highlight some industry developments from 2017 and offer a snapshot of what the New Year may hold, such as an increased demand for tele-dermatology, topical scar treatments, silicon-based scar treatments and hair transplantation services.

Poll

View Results